Hester Biosciences reports Q1 FY26 financial results
Hester Biosciences reports Q1 FY26 financial results. Hester Biosciences has announced its financial results for the quarter ended June 30, 2026. The company reported revenue of ₹123.4 crore and net profit of ₹18.7 crore. Results reflect stable growth in animal healthcare demand.
📊 STOCKS: $HESTERBIO | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Earnings
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.